Example: tourism industry
COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS …
acceptable without further justification. Wider acceptance limits may be acceptable but should be justified by showing that batches ... In the case of terminal sterilisation in the final container by heat using a reference condition of the Ph. Eur., only the time and temperature of the cycle and the acceptance limits of the ...
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
active substance, excipient and primary container ...
www.ema.europa.euactive substance, excipient and primary container Draft agreed by QWP and BWP December 2015 ... Although, terminal sterilisation using a reference condition of the European Pharmacopoeia (Ph. Eur.) ... To ensure an acceptable level of bacterial
Q1A(R2) - ICH
database.ich.orgThe intermediate storage condition has been changed from 30°C ± 2°C/60% ... the United States would be mutually acceptable to the other two regions, provided ... container closure system that is the same as or simulates the packaging proposed for storage and distribution.
ASEAN GUIDELINE ON STABILITY STUDY OF DRUG PRODUCT …
www.asean.orgContainer Closure System 12 ... its specified packaging material and stored at the established storage condition within the ... at least two pilot scale batches are acceptable. • For critical dosage forms (e.g., prolonged release forms) or when the drug ...
A GUIDE TO LOW RESISTANCE TESTING
www.testequipmentdepot.comalloy wire sealed in a container filled with paraffin was used as a standard. This was used for 20 years while studies were ... ability to measure 10 milli-ohms was acceptable, but, in the present industrial electronic environments, the field test ... vibration, temperature or other condition that may occur at the test site.
Maintenance Aspects of Owning Your Own Aircraft
www.faasafety.govcondition, and leaks. • Check condition of fuel lines for leaks (fuel stains) and security. • Drain at least one pint of fuel from each fuel filter, each fuel tank sump, and any other aircraft fuel drain into a clean, transparent container to check for water, …
SECTION 5 Methods of sampling and analysis
www.fao.orgcontainer; t 5IF TBNQMJOH QSFDBVUJPOT SFRVJSFE CZ UIF DIF-mical and microbiological methods of analysis. All tools and auxiliary materials should be inert, and in a clean condition before and after their use. In the same manner, cleaning of the contai-ners to be sampled is …
Pointers on Shipping: Clinical Samples, Biological ...
www.fedex.comcomply with the minimum acceptable size. (See “FedEx Clinical Pak” on the following page.) For Biological Substance Category B (UN 3373), the minimum outer-container size in the smallest overall external dimension is 10cm (4 inches). Each completed package must be capable of withstanding a 1.2-meter (4-foot) drop test outlined in IATA 6.6.1.
STABILITY TESTING OF ACTIVE PHARMACEUTICAL …
www.who.int125 2.2.4 Container closure system 126 2.2.5 Specification 127 2.2.6 Testing frequency 128 2.2.7 Storage conditions 129 2.2.8 Stability commitments 130 2.2.9 Evaluation 2.2.10 Statements and131 labelling 132 2.2.11 In-use and hold-time stability 133 2.2.12 Variations 2.2.13 Ongoing stability134 studies 3. Glossary 135 References 136 137 ...
MATERIAL SAFETY DATA SHEET 1. Product and Company ...
www.rbnainfo.comMar 26, 2010 · Consumer Commodity, ID 8000 if acceptable to the air carrier. space U.S. - CERCLA/SARA - Section 313 - Emission Reporting Isopropanol 67-63-0 1.0 % de minimis concentration (only if manufactured by the strong acid process, no supplier notification) US Federal regulations This product is a "Hazardous Chemical" as defined by the OSHA Hazard